The information provided in this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
Contact Information: For questions about this CME activity contact AMDA’s Education Department at 410-740-9743 or at email@example.com
Instructions for Course Participation
Sponsored by the American Medical Directors Association (AMDA)
Release Date: 06/2011 Valid through: 06/2014
Click here for a list of Management and Clinical credit designations.
The American Medical Directors Association (AMDA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Medical Directors Association designates this educational activity for a maximum of 133 AMA PRA Category 1 Credit((s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AMDA Certification Program (AMDCP) Credit Designation
This seminar has been approved for a total of 133 credit hours toward certification as a Certified Medical Director in Long Term Care (CMD). 99.5 credits have been designated as Management education credits and 33.5 hours have been designated as Clinical education credits. The AMDA CMD program is administered by the American Medical Directors Certification Program. Each physician should claim only those hours of credit actually spent on the activity.
ACCME STANDARDS FOR COMMERCIAL SUPPORT
As an ACCME accredited provider of CME, AMDA adheres to all elements of the ACCME Standards for Commercial Support?. Individuals in a position to control the content of this education activity were required to disclose all relevant financial relationships with any commercial interest to AMDA. Disclosures were reviewed by the AMDA Education Department to identify any conflicts of interest and methods of conflict resolution were conducted for each of the identified conflicts. Individual presenter’s disclosures can be found within the CME information for each session.
AMDA wishes to gratefully acknowledge the Program Planning Committee for their dedication to AMDA education and Long Term Care Medicine - 2011.
2011 Planning Committee Members
Matthew S. Wayne, MD, CMD (2011 Program Chair)
Heidi K. White, MD, CMD (Vice Chair)
Priscilla F. Bade, MD, FACP, CMD
Paul Drinka, MD, CMD, AGSF
Mary P. Evans, MD, CMD
Rosina M. Finley, MD, CMD
Thomas Rex Flygt, MD, CMD
Aida Wen, MD, CMD
Suzanne Gillespie, MD
William N. Hovland, MD, CMD
Robert G. Kaplan, MD, CMD, FACP
Karl Steinberg, MD, CMD
Carl Suchar, DO, CMD, PA
Aida Wen, MD, CMD
Bonnie Wirfs, MD, CMD
According to AMDA and ACCME policy, all those in a position to control content are required to disclose any relevant financial relationships.
Suzanne Gillespie, MD – AMDA Pfizer QI: Grant Recipient
Karl Steinberg, MD, CMD – GlaxoSmithKline, Boehringer Ingelheim, Forest Pharmaceuticals, Inc.: Speakers Bureau; California Association of Health Facilities, California Association of Long Term Care Medicine: Advisor; Watson Pharmaceuticals, Inc., Barr, Pfizer: Stockholder
Matthew S. Wayne, MD, CMD – Forest Pharmaceuticals, Inc., Boerhringer Ingelheim Pharmaceuticals, Inc.: Speakers Bureau
Heidi K. White, MD, CMD – Amgen: Principle Investigator; Merck: Co-Investigator
All other Program Committee members actively involved in planning reported they have nothing relevant to disclose. Faculty disclosure information is provided with the individual session information for each session on the CME information page.
Medical Director, Attending Physician, Nurse (NP, DON, RN, CNA), Administrator, Consultant Pharmacist, Therapist